Tackling Emerging Challenges in Tech-enabled Trials with Beth J Hoffman, PhD, CEO of Origami Therapeutics

from The Spark · host Castor

Clinical trials are evolving to meet the needs of patients and researchers alike. However, is the industry prepared to tackle emerging challenges in tech-enabled trials? In today's episode, our guest, Beth Hoffman, CEO of Origami Therapeutics, discusses these issues and gives insights on how they can be addressed. Listen to our latest podcast now for more info!Are you a sponsor looking for technology solutions to democratize your trials? Visit our website at https://www.castoredc.com/ for more information

Episode metadata supplied by the publisher feed · Published Dec 15, 2022

Embed this episode

Attribution link and audio player

Ready to play

Tackling Emerging Challenges in Tech-enabled Trials with Beth J Hoffman, PhD, CEO of Origami Therapeutics

0:00 25:05

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Spark?

This episode is 25 minutes long.

When was this The Spark episode published?

This episode was published on December 15, 2022.

Can I download this The Spark episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!